Preventive effect of curcumin in cardiac arrhythmia
Phase 3
- Conditions
- I20.Preinfarction syndrome
- Registration Number
- IRCT2013102315122N1
- Lead Sponsor
- Mashad University of Medical Sciences, Pharmaceutical Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Age>18; diagnosis of unstable angina with clinic and para clinic finding.
Exclusion criteria:
Renal and hepatic failure; infectious diseases; NSIADS and immunosuppresion drugs consumption; curcumin sensitivity; pregnancy and feeding; malignancy; chronic inflammatory disease; cardiac arrhythmia; malabsorption syndromes
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of atrial and ventricular arrhythmia. Timepoint: Between first day to 30th day post unstable angina. Method of measurement: ECG-heart exam.
- Secondary Outcome Measures
Name Time Method Changes in myeloperoxidase serum concentration. Timepoint: in day 0,5,10,15 post unstable angina. Method of measurement: laboratory.;Changes in matrix metaloproteinase serum concentration. Timepoint: in day 0,5,10,15 post unstable angina. Method of measurement: laboratory.;Changes in IL-18 serum concentration. Timepoint: in day 0,5,10,15 post unstable angina. Method of measurement: laboratory.